These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 17728005

  • 21. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
    Zhang HZ, Wei YP, Li HG, Wang M, Liu JG, Wu C.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1307-10. PubMed ID: 16982442
    [Abstract] [Full Text] [Related]

  • 22. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S, Moriuchi T.
    Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
    Byun JH, Lee MA, Roh SY, Shim BY, Hong SH, Ko YH, Ko SJ, Woo IS, Kang JH, Hong YS, Lee KS, Lee AW, Park GS, Lee KY.
    Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371
    [Abstract] [Full Text] [Related]

  • 25. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [Abstract] [Full Text] [Related]

  • 26. Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer.
    Aljada IS, Ramnath N, Donohue K, Harvey S, Brooks JJ, Wiseman SM, Khoury T, Loewen G, Slocum HK, Anderson TM, Bepler G, Tan D.
    J Clin Oncol; 2004 Aug 15; 22(16):3218-29. PubMed ID: 15249585
    [Abstract] [Full Text] [Related]

  • 27. Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients.
    Hofmann HS, Hansen G, Richter G, Taege C, Simm A, Silber RE, Burdach S.
    Clin Cancer Res; 2005 Feb 01; 11(3):1086-92. PubMed ID: 15709175
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, Morioka Y, Takahashi C, Noda M, Ito H, Wada H, Tanaka F.
    Ann Surg Oncol; 2005 Oct 01; 12(10):817-24. PubMed ID: 16132376
    [Abstract] [Full Text] [Related]

  • 31. Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.
    Werynska B, Pula B, Muszczynska-Bernhard B, Piotrowska A, Jethon A, Podhorska-Okolow M, Dziegiel P, Jankowska R.
    Anticancer Res; 2011 Sep 01; 31(9):2833-9. PubMed ID: 21868526
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
    Jung CK, Jung JH, Park GS, Lee A, Kang CS, Lee KY.
    Pathol Int; 2006 Sep 01; 56(9):503-9. PubMed ID: 16930330
    [Abstract] [Full Text] [Related]

  • 34. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K, Kawahara K.
    Oncol Rep; 2005 Jun 01; 13(6):1075-80. PubMed ID: 15870924
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H.
    Clin Cancer Res; 2006 Dec 01; 12(23):6998-7003. PubMed ID: 17145820
    [Abstract] [Full Text] [Related]

  • 38. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC).
    Karg A, Dinç ZA, Başok O, Uçvet A.
    Pathol Res Pract; 2006 Dec 01; 202(8):577-83. PubMed ID: 16814944
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 01; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.